The IgA Nephropathy risk score visual abstract
Whole Exome Sequencing, the Visual Abstract
Can you convey the findings of this study in one image? We can definitely try. See this visualization from Divya Bajpai
This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies.
in this edition: Fish Oil, GBD, Flozination meta-analysis, CHW intervention in Hispanic/Latino patients, and much more
in this edition: Atacicept in IgAN; Albuminuria as a surrogate outcome, Renal Remission and additional CONFIDENCE analysis
Can you convey the findings of this study in one image? We can definitely try. See this visualization from Divya Bajpai